|
MechanismHuman telomerase (hTERT)-directed cytolytic effects [+1] |
|
|
|
|
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Centre hospitalier régional universitaire de Besançon(CHU de Besançon)
0 Patents (Medical) associated with Centre hospitalier régional universitaire de Besançon(CHU de Besançon)
100 Deals associated with Centre hospitalier régional universitaire de Besançon(CHU de Besançon)
100 Translational Medicine associated with Centre hospitalier régional universitaire de Besançon(CHU de Besançon)